why do some people not lose weight on glp 1 need GLP-1 💉, many people know this but obesity is NOT a willpower problem. For many people it is a medical condition that does not respond to ‘just eat less and move more.’, The This One Mistake Puts GLP-1

Massive obesity market opportunity Growing diabetes prevalence globally Potential cardiovascular benefits Expanding applications beyond weight loss Strong commercial performance from current market leaders The success of Ozempic, Wegovy, Mounjaro, and Zepbound has demonstrated that obesity treatment is no longer a niche categoryit is becoming one of the most important therapeutic areas in modern medicine

Patent law is only one part of a much broader equation.The growing burden of diabetes across Africa provides an opportunity to rethink how intellectual property, public health and industrial policy interact before the continent faces another access crisis.The legal tools already exist.The more difficult question is whether governments are prepared to use them and whether the international community is willing to support a model of pharmaceutical innovation that rewards research while recognising that access to essential medicines is, ultimately, a matter of public interest.This is a co-published article, originally published on WIPR.

Dr Lauren Struszczak joins the Healthcare Today Podcast to talk about why nutrition is central to supporting patients on weight-loss medications.

GLP-1s help manage your blood sugar and can help with weight loss

Shop with expert advice from Katie & Family in their latest video LEDISA GLP-1 Patches

We also review the current state-of-knowledge as to how inhaled cannabis/cannabinoids can shape immune response in the lungs and discuss the potential consequences of altered pulmonary immunity